1. Home
  2. CRIS vs GDTC Comparison

CRIS vs GDTC Comparison

Compare CRIS & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • GDTC
  • Stock Information
  • Founded
  • CRIS 2000
  • GDTC 2018
  • Country
  • CRIS United States
  • GDTC Singapore
  • Employees
  • CRIS N/A
  • GDTC N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRIS Health Care
  • GDTC Health Care
  • Exchange
  • CRIS Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • CRIS 32.8M
  • GDTC 29.4M
  • IPO Year
  • CRIS 2000
  • GDTC 2023
  • Fundamental
  • Price
  • CRIS $3.21
  • GDTC $2.63
  • Analyst Decision
  • CRIS Strong Buy
  • GDTC Buy
  • Analyst Count
  • CRIS 3
  • GDTC 1
  • Target Price
  • CRIS $23.00
  • GDTC $5.00
  • AVG Volume (30 Days)
  • CRIS 33.0K
  • GDTC 23.3K
  • Earning Date
  • CRIS 02-18-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • CRIS N/A
  • GDTC N/A
  • EPS Growth
  • CRIS N/A
  • GDTC N/A
  • EPS
  • CRIS N/A
  • GDTC N/A
  • Revenue
  • CRIS $10,259,000.00
  • GDTC $330,254.00
  • Revenue This Year
  • CRIS N/A
  • GDTC $14.71
  • Revenue Next Year
  • CRIS N/A
  • GDTC N/A
  • P/E Ratio
  • CRIS N/A
  • GDTC N/A
  • Revenue Growth
  • CRIS 0.44
  • GDTC N/A
  • 52 Week Low
  • CRIS $2.86
  • GDTC $1.20
  • 52 Week High
  • CRIS $17.49
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 45.26
  • GDTC 44.26
  • Support Level
  • CRIS $3.05
  • GDTC $2.55
  • Resistance Level
  • CRIS $3.55
  • GDTC $2.94
  • Average True Range (ATR)
  • CRIS 0.18
  • GDTC 0.21
  • MACD
  • CRIS -0.01
  • GDTC -0.01
  • Stochastic Oscillator
  • CRIS 32.69
  • GDTC 29.03

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: